Lazy Eye Market
Lazy Eye Market Forecasts to 2030 - Global Analysis By Type (Strabismic, Refractive Amblyopia, Deprivation Amblyopia, Anisometropia Amblyopia, Reverse Amblyopia and Other Types), Diagnosis (Squint Test, General Eye Test, Visual Acuity Tests, Photo Screening and Bruckner Test), Treatment, Application and By Geography
|
Years Covered |
2022-2030 |
|
Estimated Year Value (2024) |
US $3.26 BN |
|
Projected Year Value (2030) |
US $4.92 BN |
|
CAGR (2024 - 2030) |
7.1% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Lazy Eye Market is accounted for $3.26 billion in 2024 and is expected to reach $4.92 billion by 2030 growing at a CAGR of 7.1% during the forecast period. A vision development disorder known as lazy eye, or amblyopia, occurs when one eye is unable to achieve normal visual acuity, even with prescription eyeglasses or contact lenses. It usually begins in childhood, when the eyes and brain are still growing. Amblyopia is a condition in which the brain prefers one eye over the other, impairing vision in the affected eye. Moreover, common causes include significant differences in the prescription (refractive error) between the two eyes, strabismus (misalignment of the eyes), or other conditions affecting the eyes, such as cataracts.
According to the American Academy of Ophthalmology, amblyopia, commonly known as lazy eye, is the most common cause of visual impairment in children, affecting approximately 2 to 3 out of every 100 children in the United States.
Market Dynamics:
Driver:
Growing number of amblyopia cases
Due to a number of factors, including genetic predispositions, rising birth rates, and environmental factors like screen time and fewer outdoor activities, amblyopia is becoming more commonplace worldwide. An efficient diagnosis and management approach is imperative in light of this increasing prevalence. It is imperative to detect amblyopia early on because, if left untreated, it can cause permanent visual impairments. Moreover, as healthcare providers strive to address this prevalent condition, the demand for treatment solutions is growing, driving market growth.
Restraint:
Exorbitant price of cutting-edge therapies
One major obstacle to the growth of this market is the high cost of advanced amblyopia treatments, such as digital therapy systems and specialty corrective lenses. The high costs that end users must pay for many of these cutting-edge solutions stem from the significant costs associated with their R&D, production, and marketing. Families without sufficient health insurance or those residing in low-income areas may find this financial burden especially difficult. Additionally, because of this, the cost of these treatments continues to be a major barrier to their adoption and accessibility by a variety of socioeconomic groups.
Opportunity:
Growth in emerging markets
There is a big chance for the market for amblyopia treatments to expand in emerging economies. Latin American, Asian, and African nations are all seeing increases in their economies, as well as improvements to their infrastructure for healthcare. The demand for efficient amblyopia treatments is raising as knowledge of eye health issues and disposable incomes both rise. Furthermore, a largely unexplored consumer base can be advantageous to businesses that deliberately enter these markets.
Threat:
Problems with Patient Compliance
One of the most important aspects of amblyopia treatment success is patient compliance. For many treatment modalities, like atropine drops and eye patches, to be effective, they must be used consistently over an extended period of time. But it can be difficult to keep patients compliant, particularly when they are young and may find certain treatments upsetting or stigmatizing. Moreover, non-compliance may result in less than ideal treatment results, which may lower the treatments' perceived efficacy and possibly increase the dropout rate. Improving the effectiveness of treatment and the sustainability of the market require addressing compliance issues.
Covid-19 Impact:
Due to disruptions in healthcare services and delays in routine eye examinations and treatments, the COVID-19 pandemic had a significant effect on the amblyopia treatment market. Lockdowns and other social distancing tactics decreased patient visits to ophthalmologists, which in many cases delayed the early detection and treatment of amblyopia. Additionally, some families deprioritized non-emergency healthcare, including treatment for amblyopia, due to financial strain and economic uncertainty brought on by the pandemic.
The Strabismic segment is expected to be the largest during the forecast period
The Strabismic Amblyopia segment has the largest market share in lazy eye (amblyopia). As a result of an eye misalignment known as strabismus, strabismic amblyopia is the most prevalent type of amblyopia. Poor visual development in the misaligned eye results from the brain favoring one eye over the other to prevent double vision. In order to align the eyes and improve vision, early diagnosis and treatment are essential. Furthermore, these procedures frequently involve the use of eye patches, corrective glasses, or surgery.
The Photo screening segment is expected to have the highest CAGR during the forecast period
The photo screening segment of the lazy eye (amblyopia) market is anticipated to grow at the highest CAGR. Photo screening is taking pictures of a child's eyes with specialized cameras and software. These images are then analyzed to find amblyopia risk factors like strabismus or refractive errors. Because it is quick, non-invasive, and simple to use on young children who might not cooperate for traditional eye exams, this method is especially beneficial. Moreover, this market is expanding quickly due to a number of factors, including increased adoption of pediatric screenings, photo screening technology advancements, and a growing understanding of the value of early detection.
Region with largest share:
Due to its sophisticated healthcare system, high awareness, and easy access to treatment options, North America—and especially the United States—dominate the market for lazy eyes. Because lazy eye cases are so common in the US, there is a healthy market there that is backed by strong pharmaceutical companies, esteemed research facilities, and a proactive approach to treating vision disorders. Additionally, the nation's notable market share in the North American lazy eye market can be attributed to its focus on healthcare innovation and the extensive accessibility of treatment modalities.
Region with highest CAGR:
The lazy eye market has the highest CAGR in the Asia-Pacific region, which includes nations like China, Japan, and India. Factors like rising healthcare costs, increased public awareness of eye conditions, and easier access to healthcare, especially in rural areas, are driving this growth. Furthermore, with their sizable populations, nations like China and India present substantial growth prospects because of the increased incidence of lazy eye cases and the increased attention being paid to the development of healthcare infrastructure.
Key players in the market
Some of the key players in Lazy Eye market include Johnson And Johnson Services, Inc, Golden Vision, Krafty Eye Patches, Adwia Pharmaceuticals, NovaSight, 3M, Pfizer Inc, TCI Chemicals Pvt. Ltd, Rebion, Bausch & Lomb Incorporated, Opthopatch, Vivid Vision, Inc, Hilco Vision, Walgreens and Fresnel Prism & Lens.
Key Developments:
In May 2024, Johnson & Johnson has entered into a definitive agreement to acquire Proteologix Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, for $850 million in cash, with potential for an additional milestone payment.
In January 2024, 3M Health Care announced that its Medical Solutions Division received a $34.2 million award from the U.S. Army Medical Research Acquisition Activity. The award enables 3M to develop a range of new solutions for infection prevention, wound management and wound healing.
In September 2023, Bausch + Lomb Corporation, a subsidiary of Bausch Health Companies Inc. announced it has completed its acquisition of XIIDRA® 5%, a non-steroid eye drop specifically approved to treat the signs and symptoms of dry eye disease focusing on inflammation associated with dry eye, and certain other ophthalmology assets.
Types Covered:
• Strabismic
• Refractive Amblyopia
• Deprivation Amblyopia
• Anisometropia Amblyopia
• Reverse Amblyopia
• Other Types
Diagnosis Covered:
• Squint Test
• General Eye Test
• Visual Acuity Tests
• Photo Screening
• Bruckner Test
Treatments Covered:
• Corrective Eyewear
• Surgery
• Eye Patches
• Atropine Eye Drops
• Video Game
• Other Treatments
Applications Covered:
• Hospitals
• Specialty Clinics
• Retail Pharmacies
• Eye Care Clinics
• Other Applications
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Lazy Eye Market, By Type
5.1 Introduction
5.2 Strabismic
5.3 Refractive Amblyopia
5.4 Deprivation Amblyopia
5.5 Anisometropia Amblyopia
5.6 Reverse Amblyopia
5.7 Other Types
6 Global Lazy Eye Market, By Diagnosis
6.1 Introduction
6.2 Squint Test
6.3 General Eye Test
6.4 Visual Acuity Tests
6.5 Photo Screening
6.6 Bruckner Test
7 Global Lazy Eye Market, By Treatment
7.1 Introduction
7.2 Corrective Eyewear
7.2.1 Contact Lenses
7.2.2 Glasses
7.3 Surgery
7.4 Eye Patches
7.5 Atropine Eye Drops
7.6 Video Game
7.7 Other Treatments
8 Global Lazy Eye Market, By Application
8.1 Introduction
8.2 Hospitals
8.3 Specialty Clinics
8.4 Retail Pharmacies
8.5 Eye Care Clinics
8.6 Other Applications
9 Global Lazy Eye Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Johnson And Johnson Services, Inc
11.2 Golden Vision
11.3 Krafty Eye Patches
11.4 Adwia Pharmaceuticals
11.5 NovaSight
11.6 3M
11.7 Pfizer Inc
11.8 TCI Chemicals Pvt. Ltd
11.9 Rebion
11.10 Bausch & Lomb Incorporated
11.11 Opthopatch
11.12 Vivid Vision, Inc
11.13 Hilco Vision
11.14 Walgreens
11.15 Fresnel Prism & Lens
List of Tables
1 Global Lazy Eye Market Outlook, By Region (2022-2030) ($MN)
2 Global Lazy Eye Market Outlook, By Type (2022-2030) ($MN)
3 Global Lazy Eye Market Outlook, By Strabismic (2022-2030) ($MN)
4 Global Lazy Eye Market Outlook, By Refractive Amblyopia (2022-2030) ($MN)
5 Global Lazy Eye Market Outlook, By Deprivation Amblyopia (2022-2030) ($MN)
6 Global Lazy Eye Market Outlook, By Anisometropia Amblyopia (2022-2030) ($MN)
7 Global Lazy Eye Market Outlook, By Reverse Amblyopia (2022-2030) ($MN)
8 Global Lazy Eye Market Outlook, By Other Types (2022-2030) ($MN)
9 Global Lazy Eye Market Outlook, By Diagnosis (2022-2030) ($MN)
10 Global Lazy Eye Market Outlook, By Squint Test (2022-2030) ($MN)
11 Global Lazy Eye Market Outlook, By General Eye Test (2022-2030) ($MN)
12 Global Lazy Eye Market Outlook, By Visual Acuity Tests (2022-2030) ($MN)
13 Global Lazy Eye Market Outlook, By Photo Screening (2022-2030) ($MN)
14 Global Lazy Eye Market Outlook, By Bruckner Test (2022-2030) ($MN)
15 Global Lazy Eye Market Outlook, By Treatment (2022-2030) ($MN)
16 Global Lazy Eye Market Outlook, By Corrective Eyewear (2022-2030) ($MN)
17 Global Lazy Eye Market Outlook, By Contact Lenses (2022-2030) ($MN)
18 Global Lazy Eye Market Outlook, By Glasses (2022-2030) ($MN)
19 Global Lazy Eye Market Outlook, By Surgery (2022-2030) ($MN)
20 Global Lazy Eye Market Outlook, By Eye Patches (2022-2030) ($MN)
21 Global Lazy Eye Market Outlook, By Atropine Eye Drops (2022-2030) ($MN)
22 Global Lazy Eye Market Outlook, By Video Game (2022-2030) ($MN)
23 Global Lazy Eye Market Outlook, By Other Treatments (2022-2030) ($MN)
24 Global Lazy Eye Market Outlook, By Application (2022-2030) ($MN)
25 Global Lazy Eye Market Outlook, By Hospitals (2022-2030) ($MN)
26 Global Lazy Eye Market Outlook, By Specialty Clinics (2022-2030) ($MN)
27 Global Lazy Eye Market Outlook, By Retail Pharmacies (2022-2030) ($MN)
28 Global Lazy Eye Market Outlook, By Eye Care Clinics (2022-2030) ($MN)
29 Global Lazy Eye Market Outlook, By Other Applications (2022-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
